Drug Trial Radar · NCT07012746
A Clinical Trial of the Safety and Efficacy of TJ0113 Capsules in the Treatment of Patients With Age-related Hearing Loss
Last checked: Nov 19, 2026Latest source record: Jun 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Jun 7, 2025
Primary completion
Dec 2026
Study completion Apr 2027
Sponsor
- Lead sponsor
- Yilai ShuAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Hangzhou PhecdaMed Co., Ltd.
- First posted
- Jun 10, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 65 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to explore the safety and efficacy of TJ0113 capsules in patients with age-related hearing loss.
Conditions
- Age Related Hearing Loss
- Deafness
Interventions
TJ0113 capsulesDrug
Oral intake on an empty stomach in the morning, 200 mg each time, fasting within half an hour after taking. It is recommended to keep the drug at the same time (± 1 h ) of a day .
Placebo capsulesDrug
Oral intake on an empty stomach in the morning, 200 mg each time, fasting within half an hour after taking. It is recommended to keep the drug at the same time (± 1 h ) of a day .
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety of TJ0113 capsule in the treatment of patients with age-related hearing lossTime frame: Baseline, weeks 1, 4, 12, 24, and 1 week after discontinuation
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Eye & ENT Hospital of Fudan University
Shanghai, Shanghai Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.